The usage of biological DMARDs and clinical remission of rheumatoid arthritis in China: a real-world large scale study

The aims of this study are to characterize the biological disease-modifying antirheumatic drug (bDMARD) usage patterns in real-life and examine the remission rate of rheumatoid arthritis (RA) patients receiving bDMARDs in routine clinical practice in China. Consenting RA patients (≥18 years) from 15...

Descripción completa

Detalles Bibliográficos
Autores principales: An, Yuan, Liu, Tian, He, Dongyi, Wu, Lijun, Li, Juan, Liu, Yi, Bi, Liqi, Zhou, Bin, Lin, Changsong, He, Lan, Liu, Xiangyuan, Li, Xiaofeng, Yang, Niansheng, Zhang, Zhuoli, Song, Hui, Wei, Wei, Liu, Jing, Bi, Yu, Li, Zhanguo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer London 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216094/
https://www.ncbi.nlm.nih.gov/pubmed/27709444
http://dx.doi.org/10.1007/s10067-016-3424-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216094/
https://www.ncbi.nlm.nih.gov/pubmed/27709444
http://dx.doi.org/10.1007/s10067-016-3424-5

Ejemplares similares